| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Courses and Workshops |
|
|
| |
New Drug Product Development and Lifecycle Management | |
| |
November 27, 2007 |
|
|
| |
|
|
| |
|
|
|
Drug Information Association, DIA, 800 Enterprise Rd., Suite 200, Horsham, PA, USA
Mar 27 2008
At the end of this course, participants will be able to explain the phases, major work streams, key players and interrelationships necessary to develop new drugs and to expand the lifecycle of in-line products. Interactive exercises may include creating a simple drug development plan based on the desired target product profile. Course Highlights·Overview of drug development·Candidate identification/preclinical testing·Phase I·Phase II·Phase III·Regulatory filing and review·Marketing and lifecycle management.
|
|
|
|
|
|
|
|
Organized by:
|
|
Drug Information Association |
|
|
Invited Speakers:
|
|
1) Barbara J Segen, MBASenior DirectorPfizer IncUnited States. 2) Lynn O. Wilkinson, PhD, PMPDirector, Research Project ManagementPfizer Global Research and DevelopmentUnited States.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
-
|
|
|
|
|
|
|
|
Registration:
|
|
http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=15968&eventType=Training%20Course
|
|
|
E-mail:
|
|
dia@diahome.org
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|